palmoplantar keratoderma
Recently Published Documents


TOTAL DOCUMENTS

656
(FIVE YEARS 140)

H-INDEX

39
(FIVE YEARS 4)

Author(s):  
wissal abdelli ◽  
Asmahene Souissi ◽  
Wiem Sassi ◽  
Fatima Alaoui ◽  
Mourad Mokni

Rapp-Hodgkin syndrome is a rare condition that is characterized by ectodermal dysplasia and palatal abnormalities. We describe a 15-year-old male who has Rapp-Hodgkin syndrome that is associated with a palmoplantar keratoderma.


Author(s):  
Yumeng Wang ◽  
Jianbo Wang ◽  
Yue Li ◽  
Chaolan Pan ◽  
Wange Zhou ◽  
...  

2021 ◽  
Vol 79 (6) ◽  
pp. 551-565
Author(s):  
Brian Sperelakis-Beedham ◽  
Maureen Lopez ◽  
Emmanuelle Girodon ◽  
Geoffroy Hickman ◽  
Emmanuelle Bourrat ◽  
...  

2021 ◽  
Vol 21 (04) ◽  
Author(s):  
Anli Shu

Epidermolytic palmoplantar keratoderma (EPPK) is an autosomal dominant genodermatosis caused by variants of keratin 9 (KRT9) or KRT1 gene. In this study causative gene mapping in a Chinese EPPK family was performed with Two-point linkage analysis and haplotyping. Positive linkage results were obtained on 17q (Zmax=2.06, θmax=0.0) at D17S799, which indicated KRT9 to be the most responsible gene for the family. Subsequently, direct sequencing identified a novel frameshift mutation caused by a 5bp deletion (∆GGAGG) in KRT9 in all affected individuals but not in the unaffected members or the 50 unrelated controls. The frameshift changed the encoding of the following nine amino acids and resulted in a readthrough translation in exon 7. The data revealed that the novel frameshift mutation in KRT9 was responsible for the Chinese EPPK pedigree. The researchers’ findings broaden the spectrum of KRT9 variants and provide further evidence for the highly genetic heterogeneity of EPPK.


Author(s):  
Yuko Kuriyama ◽  
Akira Shimizu ◽  
Saki Kanai ◽  
Yoko Yokoyama ◽  
Masahito Yasuda ◽  
...  

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Yue Li ◽  
Yumeng Wang ◽  
Yan Ming ◽  
Pan Chaolan ◽  
Zhang Jia ◽  
...  

Abstract Background Pachyonychia congenita (PC, OMIM #167200, #167210, #615726, #615728, and #615735) is a rare autosomal dominant disorder caused by keratin gene mutations in KRT6A,KRT6B,KRT6C,KRT16 or KRT17. It is characterized with nail dystrophy and palmoplantar keratoderma (PPK). The most prominent manifestation is plantar pain. This is a further unusual case of parental mosaicism in PC. Although very rare, germ cell mosaicism should be considered when providing genetic counselling for unaffected parents of a child with PC. Case presentation We report the case of a 5-year-old boy with thickening nails and oral leukokeratosis at birth. He began to develop palmoplantar keratoderma at 2 years old and his sister has similar clinical manifestation characterized with nail discoloration and thickening. A previously reported heterozygous mutation, p.Ile462Asn, was identified in KRT6A in the proband and his affected sister. SNaPshot sequencing revealed mosaicism at a level of 2.5% and 4.7% in DNA from blood and hair bulbs from the unaffected mother. HiSeq deep sequencing demonstrated low-grade mosaicism in the patient’s younger sister and parents. Conclusion These findings indicate the ability of WES and SNaPshot sequencing to detect low-frequency mosaic mutations. Although very rare, germinal mosaicism should be considered when genetic counseling is given to families with presumed spontaneous cases of PC.


2021 ◽  
Vol 27 (5) ◽  
pp. 358-361
Author(s):  
PT Yu ◽  
Stephanie Ho ◽  
SC Ng ◽  
FM Lo ◽  
HM Luk

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Damiano Abeni ◽  
Roberta Rotunno ◽  
Andrea Diociaiuti ◽  
Simona Giancristoforo ◽  
Domenico Bonamonte ◽  
...  

Abstract Background Autosomal recessive congenital ichthyoses (ARCI) are a genetically heterogeneous group of rare and chronic disorders characterized by generalized skin scaling and hyperkeratosis, erythroderma, and palmoplantar keratoderma. Additional features include ectropion, eclabium, ear deformities, foul-smell, joints contractures and walking problems, recurrent infections, as well as pruritus and pain. No curative therapy is available and disease care mainly relies on daily application of topical emollients and keratolytics to the whole-body surface. Altogether, disease signs and symptoms and treatment modalities have a major impact on quality of life of patients and their caregivers. However, very few studies have evaluated the family disease burden in ARCI. Methods We have performed an Italian multicenter cross-sectional study to assess the secondary disease impact on family members of pediatric and adult patients with ARCI, using a validated dermatology-specific questionnaire, the family dermatology life quality index (FDLQI). Disease severity was assessed by the dermatologist in each center. Results Seventy-eight out of 82 patients who were accompanied by at least one family member filled the FDLQI. Forty-eight (61.5%) patients were aged less than 18 years. The mean FDLQI score was 10.3 (median 10), and the most affected dimensions were (1) time needed for care, (2) extra-housework, and (3) household expenditure. Higher total FDLQI score significantly correlated with more severe disease score (P = 0.003). Features associated with greater family burden included recurrent infections (P = 0.004), foul-smell (P = 0.009), palmoplantar keratoderma (P = 0.041), but also presence of scales on the face (P = 0.039) and ear deformities (P = 0.016). Conclusions Our findings highlight the major socio-economic and psychological burden imposed by ARCI on the QoL of family caregivers. In addition, they show that global evaluation of disease impact also on family members is an essential part of patient-reported outcomes. Finally, our data underline the need to develop specific measures for family support.


Sign in / Sign up

Export Citation Format

Share Document